Structure Basis for Inhibition of SARS-CoV-2 by the Feline Drug GC376
Authors:
Preprint
Abstract
The pandemic of SARS-CoV-2 coronavirus disease-2019 (COVID-19) caused by SARS-COV-2 continues to ravage many countries in the world. Mpro is an indispensable protein for viral translation in SARS-CoV-2 and a potential target in high-specificity anti-SARS-CoV-2 drug screening. In this study, to explore potential drugs for treating COVID-19, we elucidated the structure of SARS-CoV-2 Mpro and explored the interaction between Mpro and GC376, an antiviral drug used to treat a range of coronaviruses in Feline via inhibiting Mpro. The availability and safety of GC376 were proved by biochemical and cell experiments in vitro. We determined the structure of an important protein, Mpro, in SARS-CoV-2, and revealed the interaction of GC376 with the viral substrate and inhibition of the catalytic site of SARS-CoV-2 Mpro.Keywords
All Related Versions
- Published version: Acta Pharmacologica Sinica, 44 (1), 255.
This publication has 13 references indexed in Scilit:
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitorsScience, 2020
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitorsNature, 2020
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)Nature Reviews Drug Discovery, 2020
- The crystal structure of main protease from mouse hepatitis virus A59 in complex with an inhibitorBiochemical and Biophysical Research Communications, 2019
- Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitisJournal of Feline Medicine and Surgery, 2017
- ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromoleculesNucleic Acids Research, 2016
- Structural and inhibitor studies of norovirus 3C-like proteasesVirus Research, 2013
- Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and CoronavirusesJournal of Virology, 2012
- Calicivirus 3C-Like Proteinase Inhibits Cellular Translation by Cleavage of Poly(A)-Binding ProteinJournal of Virology, 2004
- Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS DrugsScience, 2003